Regulatory News

Extension of exercise period of warrants

BASKERVILLE CAPITAL PLC (“Baskerville” or “the Company”) Extension of exercise period of warrants Baskerville (BASK) has warrants outstanding over 2,000,000 ordinary shares exercisable at 2.5p per share and over 11,500,000 ordinary shares exercisable at 7.5p per share. These warrants will expire on the second anniversary of the Company’s listing, being 22 September 2019.  The directors […]

Extension of exercise period of warrants Read More »

Half-year Report

BASKERVILLE CAPITAL PLC (“Baskerville” or “the Company”) Interim Report for the six months ended 31 December 2018 Baskerville (BASK) announces its unaudited interim financial results for the six months ended 31 December 2018. Period events: ·     Loss of £53,146 ·     Cash balances of over £1.5m at period end Rodger Sargent, Chairman of Baskerville said: “Although there have been no

Half-year Report Read More »

Baskerville Cap PLC – Director/PDMR Shareholding

Baskerville Capital PLC (the “Company”) Director / PDMR Shareholding Baskerville Capital PLC (LSE: BASK), a newly established company formed to acquire a company or business with a technology focus, announces that 1,000,000 warrants over ordinary shares of £0.005, with an exercise price of £0.025, have been transferred from Christopher Akers, Founder, to Rodger Sargent, Non-executive Director & Chairman, at no

Baskerville Cap PLC – Director/PDMR Shareholding Read More »

Baskerville Capital – First Day of Dealings

Baskerville Capital PLC (the “Company”) First Day of Dealings Placing to raise £1.8m Admission to the Official List Baskerville Capital PLC (LSE: BASK), a newly established company formed to acquire a company or business with a technology focus, announces that it has successfully raised gross proceeds of £1.8m through the placing of 36,000,000 Ordinary Shares at a price of £0.05 per Ordinary

Baskerville Capital – First Day of Dealings Read More »

Scroll to Top